IBT
RVNC
International Biotechnology Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $3.31M | Hold |
288,726
| – | – | 1.11% | 25 |
|
2023
Q2 | $7.3M | Buy |
288,726
+105,726
| +58% | +$2.67M | 2.22% | 15 |
|
2023
Q1 | $5.89M | Buy |
183,000
+63,000
| +53% | +$2.03M | 1.64% | 22 |
|
2022
Q4 | $2.21M | Hold |
120,000
| – | – | 0.68% | 34 |
|
2022
Q3 | $3.24M | Buy |
+120,000
| New | +$3.24M | 1.04% | 28 |
|